The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak
oleh: Emmie de Wit, Darryl Falzarano, Clayton Onyango, Kyle Rosenke, Andrea Marzi, Melvin Ochieng, Bonventure Juma, Robert J. Fischer, Joseph B. Prescott, David Safronetz, Victor Omballa, Collins Owuor, Thomas Hoenen, Allison Groseth, Neeltje van Doremalen, Galina Zemtsova, Joshua Self, Trenton Bushmaker, Kristin McNally, Thomas Rowe, Shannon L. Emery, Friederike Feldmann, Brandi Williamson, Tolbert G. Nyenswah, Allen Grolla, James E. Strong, Gary Kobinger, Ute Stroeher, Mark Rayfield, Fatorma K. Bolay, Kathryn C. Zoon, Jorgen Stassijns, Livia Tampellini, Martin de Smet, Stuart T. Nichol, Barry Fields, Armand Sprecher, Heinz Feldmann, Moses Massaquoi, Vincent J. Munster
| Format: | Article |
|---|---|
| Diterbitkan: | Centers for Disease Control and Prevention 2016-02-01 |
Deskripsi
Malaria is a major public health concern in the countries affected by the Ebola virus disease epidemic in West Africa. We determined the feasibility of using molecular malaria diagnostics during an Ebola virus disease outbreak and report the incidence of Plasmodium spp. parasitemia in persons with suspected Ebola virus infection.